Bicycle Therapeutics Ltd Dividends
The next dividend date for Bicycle Therapeutics Ltd has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Bicycle Therapeutics Ltd (BCYC)
More About Bicycle Therapeutics Ltd
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle tumor-targeted immune cell agonist molecule, which is in phase I/II targeting nectin-4 and agonizing CD137; and BT1702, a theranostic BRC molecule targeting MT1-MMP for which IND-enabling activities are ongoing. In addition, it develops Novel CNS targets, which is in preclinical trial targeting CNS disease; Novel neuromuscular targets, which is in preclinical trial targeting neuromuscular disease; and programs that are in preclinical trial targeting radiopharmaceutical. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas. It has collaboration and license agreement with Bayer Consumer Care AG; Novartis Pharma AG; Ionis Pharmaceuticals, Inc.; Genentech, Inc; and AstraZeneca AB. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.
Owning Bicycle Therapeutics Ltd Stock on the Dividend Date
If you own Bicycle Therapeutics Ltd stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Bicycle Therapeutics Ltd stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Bicycle Therapeutics Ltd stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Bicycle Therapeutics Ltd stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Bicycle Therapeutics Ltd dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Bicycle Therapeutics Ltd Dividends
You can contact us any time if you would like to ask questions about Bicycle Therapeutics Ltd dividends or anything else related to the stock market.